Amanote Research
Register
Sign In
FBXL10 Contributes to the Progression of Nasopharyngeal Carcinoma via Involving in PI3K/mTOR Pathway
Neoplasma
- Slovakia
doi 10.4149/neo_2015_112
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Date
January 1, 2015
Authors
Y. REN
L. WU
X. LI
W. LI
Y. YANG
M. ZHANG
Publisher
AEPress, s.r.o.
Related search
ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal Carcinoma
Frontiers in Cell and Developmental Biology
Developmental Biology
Cell Biology
Apoptotic Effects of Xanthium Strumarium via PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
Human Nasopharyngeal Carcinoma Can Be Radiosensitized by Trichosanthin via Inhibition of the PI3K Pathway
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Capsaicin Induces Autophagy and Apoptosis in Human Nasopharyngeal Carcinoma Cells by Downregulating the PI3K/AKT/mTOR Pathway
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Overexpression of the Clock Gene Per2 Suppresses Oral Squamous Cell Carcinoma Progression by Activating Autophagy via the PI3K/AKT/mTOR Pathway
Journal of Cancer
Oncology
Inhibition of Autophagy via Activation of PI3K/Akt/mTOR Pathway Contributes to the Protection of Hesperidin Against Myocardial Ischemia/Reperfusion Injury
International Journal of Molecular Medicine
Medicine
Genetics
Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy
Clinical Cancer Drugs
Cancer Research
Toxicology
Oncology
Pharmaceutics
Pharmacology
Exosomes Play an Important Role in the Progression of Plasma Cell Mastitis via the PI3K-Akt-mTOR Signaling Pathway
Mediators of Inflammation
Immunology
Cell Biology
Correction To: Elevated TRIP13 Drives the AKT/mTOR Pathway to Induce the Progression of Hepatocellular Carcinoma via Interacting With ACTN4
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
